Aktie A0ESY1 QUANTRX BIOMEDICAL CORPORATION
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen QuantRx Biomedical Corporation

Aktien

A0ESY1

US74765N1090

QTXB

Markt geschlossen - OTC Markets
Andere Börsenplätze
 19:37:42 26.02.2024 		% 5 Tage % 1. Jan.
0,004 USD -.--% Intraday Chart für QuantRx Biomedical Corporation -.--% -49,37 %
2022 QuantRx Biomedical Corporation meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 30. September 2022 CI
2022 Michael Abrams tritt als Mitglied des Verwaltungsrats der QuantRx Biomedical Corporation zurück CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
QUANTRX BIOMEDICAL CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
QuantRx Biomedical Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
QuantRx Biomedical : Management Change/Compensation - Form 8-K
Michael Abrams Resigns as a Member of the Board of Directors of QuantRx Biomedical Corporation
QUANTRX BIOMEDICAL CORP : Change in Directors or Principal Officers (form 8-K)
QUANTRX BIOMEDICAL CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
QuantRx Biomedical Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
QUANTRX BIOMEDICAL CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
QuantRx Biomedical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022
QUANTRX BIOMEDICAL CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
QuantRx Biomedical Corporation Reports Earnings Results for the Full Year Ended December 31, 2021
QuantRx Biomedical Corporation Auditor Raises 'Going Concern' Doubt
QUANTRX BIOMEDICAL CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
QuantRx Biomedical Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
QUANTRX BIOMEDICAL : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
Quantrx Biomedical Corporation Reports Earnings Results for the Second Quarter Ended June 30, 2021
QUANTRX BIOMEDICAL : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
Quantrx Biomedical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2021
QUANTRX BIOMEDICAL : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
Quantrx Biomedical Corporation Reports Earnings Results for the Full Year Ended December 31, 2020
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A0ESY1 Aktie
  4. Nachrichten QuantRx Biomedical Corporation
  5. Andere Sprachen